Гепатит Е

Disparities in detection of antibodies against hepatitis E virus in US blood donor samples using commercial assays.   (741,05kb) (Zafrullah M, Zhang X, Tran C, Nguyen M, Kamili S, Purdy MA, Stramer SL. //Transfusion. 2018 May; 58(5):1254-1263)

 

Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E.  (654,29kb) (Kodani M, Kamili NA, Tejada-Strop A, Poe A, Denniston MM, Drobeniuc J, Kamili S. // J Med Virol. 2017 Jun;89(6):1055-1061)

 

Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010  (149,04kb) (Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Teo CG, Holmberg SD.// J Infect Dis. 2015 Feb 1; 211(3):366-73)

 

Hepatitis E virus seroprevalence in patients with HIV in Nizhny Novgorod, Russia (16,31kb) (I.N.Sharipova, A.V.Berezhnaya, V.F.Puzyrev, A.N.Burkov, T.I.Ulanova; International Symposium HIV and Emerging Infectious Diseases 2014 Marseille, France. 21-23 May )

 

Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients (1,58Mb) (Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, van der Eijk AA.// J Clin Virol. 2013 Dec;58(4):629-34)

 

AVIDITY OF SPECIFIC IMMUNOGLOBULIN G FOR THE DETECTION OF HEPATITIS E PRIMARILY INFECTION  (62,35kb) (O.Fedotcheva, J.Pticina, E.Matveeva, A.Burkov, T.Ulanova, A.Obriadina; 24 th European Congress of Clinical Microbiology and Infections Diseases, Barcelona. Spain. 10-13 May 2014 – Р1926)

 

ГЕПАТИТ Е СРЕДИ БЕРЕМЕННЫХ ЕГИПТА И РОССИИ: ЧАСТОТА ВЫЯВЛЕНИЯ АНТИ-ВГЕ (135.7Kb)

(ИБРАГИМ ЕЛ-МОРСИ ИБРАГИМ, О.В.ПОПОВА, А.Н.БУРКОВ, М.И.МИХАЙЛОВ, Инф. бюллетень «Вирусные гепатиты. Достижения и перспективы.» .- 2003.- № 3(18).-С.15-16)

 

DETECTION OF ANTIBODY TO HEPATITIS E VIRUS (HEV) USING TWO NEW RECOMBINANT PROTEINS (12.9Kb)

(A.OBRIADINA, J.H.MENG, T.ULANOVA, K.TRINTA, A.N. BURKOV, H.A. FIELDS,Y.E.KHUDYAKOV ;XII International Congress of Virology.- Paris, France, 2002.- Vol.1028)

 

ANTIGENIC PROPERTIES OF THE ARTIFICIAL MOSAIC PROTEINS OF HEPATITIS E VIRUS (13.9Kb)

(A.P.OBRIADINA, T.I.ULANOVA, A.N.BURKOV, H.A.FIELDS, Y.E.KHUDYAKOV ; World Congress of Virology, Paris, July, 2002)

 

DETECTION AND CHARACTERISATION OF SWINE HEPATITIS E VIRUS IN NEW ZEALAND (242.9Kb)

(O.GARKAVENKO, A.OBRIADINA, J.MENG, D.A.ANDERSON, H.J.BENARD, B.A.SCHROEDER,Y.E.KHUDYAKOV, Н.A.FIELDS, M.C.CROXSON , J. Med Virol. 2001 Nov; 65(3):525-529)

 

ARTIFICIAL MOSAIC ANTIGEN OF THE HEPATITIS E VIRUS (23.7Kb)

(T.I.ULANOVA, A.P.OBRIADINA, A.N.BURKOV, H.A.FIELDS, Y.E.KHUDYAKOV , American Society for Virology, 20th Annual Meeting, Madison. - USA, 2001. - Р.197 (P 26-9).

 

A NEW ARTIFICAL ANTIGEN OF THE HEPATITIS E VIRUS

(T.I.ULANOVA , A.P.OBRIADINA , G.TALEKAR , A.N.BURKOV, H.A.FIELDS , Y.E. KHUDYAKOV , J. Immunoassay Immunochem. 2009; 30(1):18-39.)

 

ANTIGENIC PROPERTIES OF RECOMBINANT PROTEINS OF HEPATITIS E VIRUS (HEV)

(A.OBRIADINA, J.H.MENG, T.ULANOVA, A.BURKOV, H.A.FIELDS, Y.E.KHUDYAKOV , 20th Annual Meeting, Madison.- USA, 2001.- P.169 (Р.5-2)

 

A NEW ENZYME IMMUNOASSAY FOR THE DETECTION OF ANTIBODIES AGAINST THE HEPATITIS E VIRUS (65.8Kb)

(A.OBRIADINA, J.H.MENG, T.ULANOVA, A.BURKOV, H.A.FIELDS, Y.E.KHUDYAKOV , American Society for Virology, 20th Annual Meeting, Madison.- USA, 2001.- P.169 (Р.5-2)

 

PREVALENCE OF ANTI-HEV IN VETERANS WHO HAVE BEEN AT WAR OR HAVE NOT BEEN AT WAR IN AFGHANISTAN IN 1979-1989(24Kb)

(M.I.MICHAILOV, I.AL MORSI, O.E.POPOVA, J.DROBENJUK, A.I.YUROVSKIH, T.E.SNITKOVSKAYA,V.V.ROMANENKO, A.N.BURKOV, 12 th International Symposium on Viral Hepatitis and Liver Disease, Paris, 2006.-P.465)

 

Serologic  Assays Specific to Immunoglogulin M Antibodies against Hepatitis E Virus: Pangenotypic Evaluation of Performances  (699,29kb) (Jan Drobeniuc,1 Jihong Meng,12 Gabor Reuter,3 Tracy Greene-Montfort,1 Natasha Khudyakova,1 Zoya Dimitrova,1 Saleem Kamili,1 and Chong-Gee Teo1     'Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia; 2Research Center of Clinical Medicine, Southeast University School of Medicine, Nanjing, China; and 3Regional  Laboratory of Virology, ANTSZ Regional Institute of State Public Health  Service, Pecs, Hungary)

 

Laboratorybased_surveillance_2013 (635,34kb) (Jan Drobeniuc, Tracy Greene-Montfort, Ngoc-Thao Le, Tonya R. Mixson-Hayden, Lilia Ganova-Raeva, Chen Dong, Ryan T. Novak, Umid M. Sharapov, Rania A. Tohme, Eyasu Toshale, Saleem Kamili, and Chong-Gee Teo)